Literature DB >> 16527607

SATR-1 hypomethylation is a common and early event in breast cancer.

Fabrício F Costa1, Valeria A Paixão, Felicia P Cavalher, Karina B Ribeiro, Isabela W Cunha, José Augusto Rinck, Michael O'Hare, Alan Mackay, Fernando A Soares, Ricardo R Brentani, Anamaria A Camargo.   

Abstract

Genome stability and normal gene expression are maintained by a fixed and predetermined DNA methylation pattern, which becomes abnormal in malignant cells. Hypomethylation of satellite DNA sequences is frequently found in tumors and has been associated with an increased frequency of DNA rearrangements and chromosome instability. In this work, we used methylation-sensitive arbitrarily primed polymerase chain reaction (MSAP-PCR) to identify differentially methylated DNA fragments in normal and tumor breast samples. We identified a novel differentially methylated fragment located on chromosome 5 with high similarity to a SATR-1 satellite sequence. This fragment was found to be hypomethylated in 63% of breast tumor cell lines and in 86% of breast tumors relative to normal breast tissue. We found that normal tissue adjacent to breast tumors displayed a variable decrease in methylation and that the decrease observed for most of these adjacent samples was higher than observed for normal breast tissue derived from reduction mammoplasty. The methylation decrease was, however, significantly higher in tumor samples than in adjacent tissue (chi2= 154, 1 df, P < 10(-4)), suggesting that SATR-1 hypomethylation frequently occurs in the early stages of tumor development. Our results highlight the importance of global DNA hypomethylation as a contributing factor in breast tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527607     DOI: 10.1016/j.cancergencyto.2005.07.023

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  18 in total

Review 1.  Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules.

Authors:  Pilar Blancafort; Jian Jin; Stephen Frye
Journal:  Mol Pharmacol       Date:  2012-11-13       Impact factor: 4.436

Review 2.  DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer.

Authors:  Johanna K Samuelsson; Sergio Alonso; Fumiichiro Yamamoto; Manuel Perucho
Journal:  Mutat Res       Date:  2010-09-17       Impact factor: 2.433

3.  Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia.

Authors:  Sonia Fabris; Valentina Bollati; Luca Agnelli; Fortunato Morabito; Valeria Motta; Giovanna Cutrona; Serena Matis; Anna Grazia Recchia; Vincenzo Gigliotti; Massimo Gentile; Giorgio Lambertenghi Deliliers; Pier Alberto Bertazzi; Manlio Ferrarini; Antonino Neri; Andrea Baccarelli
Journal:  Epigenetics       Date:  2011-02-01       Impact factor: 4.528

4.  Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment.

Authors:  Fabricio F Costa; Elisabeth A Seftor; Jared M Bischof; Dawn A Kirschmann; Luigi Strizzi; Kelly Arndt; Maria de Fatima Bonaldo; Marcelo B Soares; Mary J C Hendrix
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

5.  The role of MTHFR gene in multiple myeloma.

Authors:  Elias Zintzaras; Stavroula Giannouli; Paraskevi Rodopoulou; Michael Voulgarelis
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

Review 6.  Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review).

Authors:  Mudit Vaid; Joanna Floros
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

7.  Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter.

Authors:  Marzena A Lewandowska; Fabricio F Costa; Jared M Bischof; Sarah H Williams; Marcelo B Soares; Ann Harris
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-23       Impact factor: 6.914

8.  Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity.

Authors:  Christopher A Hamm; Hehuang Xie; Fabricio F Costa; Elio F Vanin; Elisabeth A Seftor; Simone T Sredni; Jared Bischof; Deli Wang; Maria F Bonaldo; Mary J C Hendrix; Marcelo B Soares
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

Review 9.  Breast cancer epigenetics: from DNA methylation to microRNAs.

Authors:  Jürgen Veeck; Manel Esteller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-01-27       Impact factor: 2.673

10.  Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.

Authors:  Edneia A S Ramos; Anamaria A Camargo; Karin Braun; Renata Slowik; Iglenir J Cavalli; Enilze M S F Ribeiro; Fábio de O Pedrosa; Emanuel M de Souza; Fabrício F Costa; Giseli Klassen
Journal:  BMC Cancer       Date:  2010-01-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.